Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
5 min read
Mimetogen Pharmaceuticals Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Mimetogen Pharmaceuticals, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
OncoSec Medical Incorporated Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of OncoSec Medical Incorporated, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
InnoCare Pharma Limited Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of InnoCare Pharma Limited, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
Interius BioTherapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Interius BioTherapeutics, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
Intralytix Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Intralytix, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
G-treeBNT Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of G-treeBNT Co., Ltd, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
Immunethep Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Immunethep, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
ImmusanT Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of ImmusanT, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
MAX BioPharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of MAX BioPharma, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
Etubics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of Etubics, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
GinkgoPharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of GinkgoPharma, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.
Latest Hotspot
5 min read
InflaRx N.V Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
23 July 2026
A 2026 partnering scan of InflaRx N.V, covering pipeline ownership and stage, evidence requirements, IP risk, deal precedent, financial signals and a prioritized outreach shortlist.